Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 565

1.

Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases.

Bousquet JJ, Schünemann HJ, Togias A, Erhola M, Hellings PW, Zuberbier T, Agache I, Ansotegui IJ, Anto JM, Bachert C, Becker S, Bedolla-Barajas M, Bewick M, Bosnic-Anticevich S, Bosse I, Boulet LP, Bourrez JM, Brusselle G, Chavannes N, Costa E, Cruz AA, Czarlewski W, Fokkens WJ, Fonseca JA, Gaga M, Haahtela T, Illario M, Klimek L, Kuna P, Kvedariene V, Le LTT, Larenas-Linnemann D, Laune D, Lourenço OM, Menditto E, Mullol J, Okamoto Y, Papadopoulos N, Pham-Thi N, Picard R, Pinnock H, Roche N, Roller-Wirnsberger RE, Rolland C, Samolinski B, Sheikh A, Toppila-Salmi S, Tsiligianni I, Valiulis A, Valovirta E, Vasankari T, Ventura MT, Walker S, Williams S, Akdis CA, Annesi-Maesano I, Arnavielhe S, Basagana X, Bateman E, Bedbrook A, Bennoor KS, Benveniste S, Bergmann KC, Bialek S, Billo N, Bindslev-Jensen C, Bjermer L, Blain H, Bonini M, Bonniaud P, Bouchard J, Briedis V, Brightling CE, Brozek J, Buhl R, Buonaiuto R, Canonica GW, Cardona V, Carriazo AM, Carr W, Cartier C, Casale T, Cecchi L, Cepeda Sarabia AM, Chkhartishvili E, Chu DK, Cingi C, Colgan E, de Sousa JC, Courbis AL, Custovic A, Cvetkosvki B, D'Amato G, da Silva J, Dantas C, Dokic D, Dauvilliers Y, Dedeu A, De Feo G, Devillier P, Di Capua S, Dykewickz M, Dubakiene R, Ebisawa M, El-Gamal Y, Eller E, Emuzyte R, Farrell J, Fink-Wagner A, Fiocchi A, Fontaine JF, Gemicioğlu B, Schmid-Grendelmeir P, Gamkrelidze A, Garcia-Aymerich J, Gomez M, González Diaz S, Gotua M, Guldemond NA, Guzmán MA, Hajjam J, O'B Hourihane J, Humbert M, Iaccarino G, Ierodiakonou D, Illario M, Ivancevich JC, Joos G, Jung KS, Jutel M, Kaidashev I, Kalayci O, Kardas P, Keil T, Khaitov M, Khaltaev N, Kleine-Tebbe J, Kowalski ML, Kritikos V, Kull I, Leonardini L, Lieberman P, Lipworth B, Lodrup Carlsen KC, Loureiro CC, Louis R, Mair A, Marien G, Mahboub B, Malva J, Manning P, De Manuel Keenoy E, Marshall GD, Masjedi MR, Maspero JF, Mathieu-Dupas E, Matricardi PM, Melén E, Melo-Gomes E, Meltzer EO, Menditto E, Mercier J, Miculinic N, Mihaltan F, Milenkovic B, Moda G, Mogica-Martinez MD, Mohammad Y, Montefort S, Monti R, Morais-Almeida M, Mösges R, Münter L, Muraro A, Murray R, Naclerio R, Napoli L, Namazova-Baranova L, Neffen H, Nekam K, Neou A, Novellino E, Nyembue D, O'Hehir R, Ohta K, Okubo K, Onorato G, Ouedraogo S, Pali-Schöll I, Palkonen S, Panzner P, Park HS, Pépin JL, Pereira AM, Pfaar O, Paulino E, Phillips J, Picard R, Plavec D, Popov TA, Portejoie F, Price D, Prokopakis EP, Pugin B, Raciborski F, Rajabian-Söderlund R, Reitsma S, Rodo X, Romano A, Rosario N, Rottem M, Ryan D, Salimäki J, Sanchez-Borges MM, Sisul JC, Solé D, Somekh D, Sooronbaev T, Sova M, Spranger O, Stellato C, Stelmach R, Suppli Ulrik C, Thibaudon M, To T, Todo-Bom A, Tomazic PV, Valero AA, Valenta R, Valentin-Rostan M, van der Kleij R, Vandenplas O, Vezzani G, Viart F, Viegi G, Wallace D, Wagenmann M, Wang Y, Waserman S, Wickman M, Williams DM, Wong G, Wroczynski P, Yiallouros PK, Yorgancioglu A, Yusuf OM, Zar HJ, Zeng S, Zernotti M, Zhang L, Zhong NS, Zidarn M; ARIA Study Group; MASK Study Group.

Clin Transl Allergy. 2019 Sep 9;9:44. doi: 10.1186/s13601-019-0279-2. eCollection 2019. Review.

2.

Idiopathic anaphylaxis yardstick: Practical recommendations for clinical practice.

Carter MC, Akin C, Castells MC, Scott EP, Lieberman P.

Ann Allergy Asthma Immunol. 2019 Sep 3. pii: S1081-1206(19)30613-1. doi: 10.1016/j.anai.2019.08.024. [Epub ahead of print]

PMID:
31513910
3.

ARID1A promotes genomic stability through protecting telomere cohesion.

Zhao B, Lin J, Rong L, Wu S, Deng Z, Fatkhutdinov N, Zundell J, Fukumoto T, Liu Q, Kossenkov A, Jean S, Cadungog MG, Borowsky ME, Drapkin R, Lieberman PM, Abate-Shen CT, Zhang R.

Nat Commun. 2019 Sep 6;10(1):4067. doi: 10.1038/s41467-019-12037-4.

4.

KSHV-encoded LANA protects the cellular replication machinery from hypoxia induced degradation.

Singh RK, Lamplugh ZL, Lang F, Yuan Y, Lieberman P, You J, Robertson ES.

PLoS Pathog. 2019 Sep 3;15(9):e1008025. doi: 10.1371/journal.ppat.1008025. eCollection 2019 Sep.

5.

ATRX loss induces telomere dysfunction and necessitates induction of alternative lengthening of telomeres during human cell immortalization.

Li F, Deng Z, Zhang L, Wu C, Jin Y, Hwang I, Vladimirova O, Xu L, Yang L, Lu B, Dheekollu J, Li JY, Feng H, Hu J, Vakoc CR, Ying H, Paik J, Lieberman PM, Zheng H.

EMBO J. 2019 Aug 27:e96659. doi: 10.15252/embj.201796659. [Epub ahead of print]

PMID:
31454099
6.

The antiquity and evolution of the neural bases of rhythmic activity.

Lieberman P.

Ann N Y Acad Sci. 2019 Aug 1. doi: 10.1111/nyas.14199. [Epub ahead of print] Review.

PMID:
31368158
7.

Correction: Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.

Dheekollu J, Malecka K, Wiedmer A, Delecluse HJ, Chiang AKS, Altieri DC, Messick TE, Lieberman PM.

Oncotarget. 2019 Jul 8;10(43):4505-4506. doi: 10.18632/oncotarget.27073. eCollection 2019 Jul 8.

8.

Development of a novel inducer for EBV lytic therapy.

Tikhmyanova N, Paparoidamis N, Romero-Masters J, Feng X, Mohammed FS, Reddy PAN, Kenney SC, Lieberman PM, Salvino JM.

Bioorg Med Chem Lett. 2019 Aug 15;29(16):2259-2264. doi: 10.1016/j.bmcl.2019.06.034. Epub 2019 Jun 22.

PMID:
31255485
9.

Elevated telomere dysfunction in cells containing the African-centric Pro47Ser cancer-risk variant of TP53.

Tutton S, Deng Z, Gulve N, Vladimirova O, Beishline K, Wiedmer A, Murphy M, Lieberman PM.

Oncotarget. 2019 Jun 4;10(38):3581-3591. doi: 10.18632/oncotarget.26980. eCollection 2019 Jun 4.

10.

Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication.

Malecka KA, Dheekollu J, Deakyne JS, Wiedmer A, Ramirez UD, Lieberman PM, Messick TE.

J Virol. 2019 May 29. pii: JVI.00487-19. doi: 10.1128/JVI.00487-19. [Epub ahead of print]

PMID:
31142669
11.

Reply.

Song TT, Lieberman P.

J Allergy Clin Immunol Pract. 2019 Jul - Aug;7(6):2097-2098. doi: 10.1016/j.jaip.2019.03.037. Epub 2019 May 2. No abstract available.

PMID:
31056449
12.

Fatty acid transport protein 2 reprograms neutrophils in cancer.

Veglia F, Tyurin VA, Blasi M, De Leo A, Kossenkov AV, Donthireddy L, To TKJ, Schug Z, Basu S, Wang F, Ricciotti E, DiRusso C, Murphy ME, Vonderheide RH, Lieberman PM, Mulligan C, Nam B, Hockstein N, Masters G, Guarino M, Lin C, Nefedova Y, Black P, Kagan VE, Gabrilovich DI.

Nature. 2019 May;569(7754):73-78. doi: 10.1038/s41586-019-1118-2. Epub 2019 Apr 17.

PMID:
30996346
13.

Penicillin Allergy Evaluation: A Prospective, Multicenter, Open-Label Evaluation of a Comprehensive Penicillin Skin Test Kit.

Solensky R, Jacobs J, Lester M, Lieberman P, McCafferty F, Nilsson T, Park M, Schwarz G, Soong W, Wagelie-Steffen A, Wedner HJ, Weiss M, Windom H, Tonascia J, Yates KP, Mendelson LM, Wolfe J, Adkinson NF.

J Allergy Clin Immunol Pract. 2019 Jul - Aug;7(6):1876-1885.e3. doi: 10.1016/j.jaip.2019.02.040. Epub 2019 Mar 13.

PMID:
30878711
14.

Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth.

Messick TE, Smith GR, Soldan SS, McDonnell ME, Deakyne JS, Malecka KA, Tolvinski L, van den Heuvel APJ, Gu BW, Cassel JA, Tran DH, Wassermann BR, Zhang Y, Velvadapu V, Zartler ER, Busson P, Reitz AB, Lieberman PM.

Sci Transl Med. 2019 Mar 6;11(482). pii: eaau5612. doi: 10.1126/scitranslmed.aau5612.

PMID:
30842315
15.

PML is recruited to heterochromatin during S phase and represses DAXX-mediated histone H3.3 chromatin assembly.

Shastrula PK, Sierra I, Deng Z, Keeney F, Hayden JE, Lieberman PM, Janicki SM.

J Cell Sci. 2019 Mar 26;132(6). pii: jcs220970. doi: 10.1242/jcs.220970.

PMID:
30796101
16.

Guiding Principles for the Recognition, Diagnosis, and Management of Infants with Anaphylaxis: An Expert Panel Consensus.

Greenhawt M, Gupta RS, Meadows JA, Pistiner M, Spergel JM, Camargo CA Jr, Simons FER, Lieberman PL.

J Allergy Clin Immunol Pract. 2019 Apr;7(4):1148-1156.e5. doi: 10.1016/j.jaip.2018.10.052. Epub 2019 Feb 5. Review.

PMID:
30737191
17.

LANA oligomeric architecture is essential for KSHV nuclear body formation and viral genome maintenance during latency.

De Leo A, Deng Z, Vladimirova O, Chen HS, Dheekollu J, Calderon A, Myers KA, Hayden J, Keeney F, Kaufer BB, Yuan Y, Robertson E, Lieberman PM.

PLoS Pathog. 2019 Jan 25;15(1):e1007489. doi: 10.1371/journal.ppat.1007489. eCollection 2019 Jan.

18.

Who needs to carry an epinephrine autoinjector?

Song TT, Lieberman P.

Cleve Clin J Med. 2019 Jan;86(1):66-72. doi: 10.3949/ccjm.86a.17123. Review.

19.

The changing face of anaphylaxis in adults and adolescents.

Pattanaik D, Lieberman P, Lieberman J, Pongdee T, Keene AT.

Ann Allergy Asthma Immunol. 2018 Nov;121(5):594-597. doi: 10.1016/j.anai.2018.07.017. Epub 2018 Jul 30.

PMID:
30071303
20.

Electronic Clinical Decision Support System for allergic rhinitis management: MASK e-CDSS.

Courbis AL, Murray RB, Arnavielhe S, Caimmi D, Bedbrook A, Van Eerd M, De Vries G, Dray G, Agache I, Morais-Almeida M, Bachert C, Bergmann KC, Bosnic-Anticevich S, Brozek J, Bucca C, Camargos P, Canonica GW, Carr W, Casale T, Fonseca JA, Haahtela T, Kalayci O, Klimek L, Kuna P, Kvedariene V, Larenas Linnemann D, Lieberman P, Mullol J, Ohehir R, Papadopoulos N, Price D, Ryan D, Samolinski B, Simons FE, Tomazic P, Triggiani M, Valiulis A, Valovirta E, Wagenmann M, Wickman M, Yorgancioglu A, Bousquet J.

Clin Exp Allergy. 2018 Dec;48(12):1640-1653. doi: 10.1111/cea.13230. Epub 2018 Aug 20.

PMID:
29999223
21.

Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma.

Reyes-Uribe P, Adrianzen-Ruesta MP, Deng Z, Echevarria-Vargas I, Mender I, Saheb S, Liu Q, Altieri DC, Murphy ME, Shay JW, Lieberman PM, Villanueva J.

Oncogene. 2018 Jul;37(30):4058-4072. doi: 10.1038/s41388-018-0247-7. Epub 2018 Apr 26.

22.

Correction: Deregulation of KSHV latency conformation by ER-stress and caspase-dependent RAD21-cleavage.

De Leo A, Chen HS, Hu CA, Lieberman PM.

PLoS Pathog. 2018 Apr 25;14(4):e1007027. doi: 10.1371/journal.ppat.1007027. eCollection 2018 Apr.

23.

Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2.

AlQarni S, Al-Sheikh Y, Campbell D, Drotar M, Hannigan A, Boyle S, Herzyk P, Kossenkov A, Armfield K, Jamieson L, Bailo M, Lieberman PM, Tsimbouri P, Wilson JB.

Oncogene. 2018 Jul;37(29):3998-4012. doi: 10.1038/s41388-018-0147-x. Epub 2018 Apr 25.

24.

TERRA and the histone methyltransferase Dot1 cooperate to regulate senescence in budding yeast.

Wanat JJ, Logsdon GA, Driskill JH, Deng Z, Lieberman PM, Johnson FB.

PLoS One. 2018 Apr 12;13(4):e0195698. doi: 10.1371/journal.pone.0195698. eCollection 2018.

25.

Anaphylaxis care guidelines and the effect on health care resource use in the United States.

Song TT, Brown D, Lehnigk U, Corvino FA, Lieberman P.

Ann Allergy Asthma Immunol. 2018 Jul;121(1):132-134.e3. doi: 10.1016/j.anai.2018.03.018. Epub 2018 Mar 19. No abstract available.

26.

CTCF-Induced Circular DNA Complexes Observed by Atomic Force Microscopy.

Mawhinney MT, Liu R, Lu F, Maksimoska J, Damico K, Marmorstein R, Lieberman PM, Urbanc B.

J Mol Biol. 2018 Mar 16;430(6):759-776. doi: 10.1016/j.jmb.2018.01.012. Epub 2018 Jan 31.

27.

Value of a Second Dose of Epinephrine During Anaphylaxis: A Patient/Caregiver Survey.

Song TT, Brown D, Karjalainen M, Lehnigk U, Lieberman P.

J Allergy Clin Immunol Pract. 2018 Sep - Oct;6(5):1559-1567. doi: 10.1016/j.jaip.2018.01.019. Epub 2018 Feb 3.

28.

RNA-Seq of Kaposi's sarcoma reveals alterations in glucose and lipid metabolism.

Tso FY, Kossenkov AV, Lidenge SJ, Ngalamika O, Ngowi JR, Mwaiselage J, Wickramasinghe J, Kwon EH, West JT, Lieberman PM, Wood C.

PLoS Pathog. 2018 Jan 19;14(1):e1006844. doi: 10.1371/journal.ppat.1006844. eCollection 2018 Jan.

29.

Allergists' opinions on anaphylaxis and epinephrine administration-a case-based survey.

Lieberman JA, Lieberman P, Wang J.

J Allergy Clin Immunol Pract. 2018 May - Jun;6(3):1075-1077.e1. doi: 10.1016/j.jaip.2017.11.031. Epub 2018 Jan 4. No abstract available.

PMID:
29306683
30.

Outcomes of Acute Partial Hospital Treatment: Comparison of Two Programs and a Waiting List Control.

Lieberman PB, Villalba R 2nd, Farris SG.

J Psychiatr Pract. 2017 Nov;23(6):401-408. doi: 10.1097/PRA.0000000000000271.

PMID:
29303947
31.

CTCF driven TERRA transcription facilitates completion of telomere DNA replication.

Beishline K, Vladimirova O, Tutton S, Wang Z, Deng Z, Lieberman PM.

Nat Commun. 2017 Dec 13;8(1):2114. doi: 10.1038/s41467-017-02212-w.

32.

Structural and functional analysis of an OB-fold in human Ctc1 implicated in telomere maintenance and bone marrow syndromes.

Shastrula PK, Rice CT, Wang Z, Lieberman PM, Skordalakes E.

Nucleic Acids Res. 2018 Jan 25;46(2):972-984. doi: 10.1093/nar/gkx1213.

33.

Identification of alpha-gal sensitivity in patients with a diagnosis of idiopathic anaphylaxis.

Carter MC, Ruiz-Esteves KN, Workman L, Lieberman P, Platts-Mills TAE, Metcalfe DD.

Allergy. 2018 May;73(5):1131-1134. doi: 10.1111/all.13366. Epub 2017 Dec 27.

PMID:
29161766
34.

Contemporary issues in anaphylaxis and the evolution of epinephrine autoinjectors: What will the future bring?

Greenberger PA, Wallace DV, Lieberman PL, Gregory SM.

Ann Allergy Asthma Immunol. 2017 Oct;119(4):333-338. doi: 10.1016/j.anai.2017.07.030.

PMID:
28958374
35.

Deregulation of KSHV latency conformation by ER-stress and caspase-dependent RAD21-cleavage.

De Leo A, Chen HS, Hu CC, Lieberman PM.

PLoS Pathog. 2017 Aug 30;13(8):e1006596. doi: 10.1371/journal.ppat.1006596. eCollection 2017 Aug. Erratum in: PLoS Pathog. 2018 Apr 25;14 (4):e1007027.

36.

Anaphylaxis associated with omalizumab administration: Risk factors and patient characteristics.

Lieberman PL, Jones I, Rajwanshi R, Rosén K, Umetsu DT.

J Allergy Clin Immunol. 2017 Dec;140(6):1734-1736.e4. doi: 10.1016/j.jaci.2017.07.013. Epub 2017 Aug 7. No abstract available.

37.

Coordinate Regulation of TET2 and EBNA2 Controls the DNA Methylation State of Latent Epstein-Barr Virus.

Lu F, Wiedmer A, Martin KA, Wickramasinghe PJMS, Kossenkov AV, Lieberman PM.

J Virol. 2017 Sep 27;91(20). pii: e00804-17. doi: 10.1128/JVI.00804-17. Print 2017 Oct 15.

38.

The Telomeric Response to Viral Infection.

Wang Z, Deng Z, Tutton S, Lieberman PM.

Viruses. 2017 Aug 9;9(8). pii: E218. doi: 10.3390/v9080218. Review.

39.

Contribution of language studies to the understanding of cognitive impairment and its progression over time in Parkinson's disease.

Auclair-Ouellet N, Lieberman P, Monchi O.

Neurosci Biobehav Rev. 2017 Sep;80:657-672. doi: 10.1016/j.neubiorev.2017.07.014. Epub 2017 Aug 3. Review.

PMID:
28782623
40.

DNA hypermethylation induced by Epstein-Barr virus in the development of Epstein-Barr virus-associated gastric carcinoma.

Choi SJ, Shin YS, Kang BW, Kim JG, Won KJ, Lieberman PM, Cho H, Kang H.

Arch Pharm Res. 2017 Aug;40(8):894-905. doi: 10.1007/s12272-017-0939-5. Epub 2017 Aug 4. Review.

PMID:
28779374
41.

Small molecule perturbation of the CAND1-Cullin1-ubiquitin cycle stabilizes p53 and triggers Epstein-Barr virus reactivation.

Tikhmyanova N, Tutton S, Martin KA, Lu F, Kossenkov AV, Paparoidamis N, Kenney S, Salvino JM, Lieberman PM.

PLoS Pathog. 2017 Jul 17;13(7):e1006517. doi: 10.1371/journal.ppat.1006517. eCollection 2017 Jul.

42.

Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.

Deakyne JS, Malecka KA, Messick TE, Lieberman PM.

J Virol. 2017 Sep 12;91(19). pii: e01046-17. doi: 10.1128/JVI.01046-17. Print 2017 Oct 1.

43.

Comment on "Monkey vocal tracts are speech-ready".

Lieberman P.

Sci Adv. 2017 Jul 7;3(7):e1700442. doi: 10.1126/sciadv.1700442. eCollection 2017 Jul.

44.

An analysis of anaphylaxis cases at a single pediatric emergency department during a 1-year period.

Wright CD, Longjohn M, Lieberman PL, Lieberman JA.

Ann Allergy Asthma Immunol. 2017 Apr;118(4):461-464. doi: 10.1016/j.anai.2017.02.002.

PMID:
28390586
45.

Effectiveness of EMDR in patients with substance use disorder and comorbid PTSD: study protocol for a randomized controlled trial.

Schäfer I, Chuey-Ferrer L, Hofmann A, Lieberman P, Mainusch G, Lotzin A.

BMC Psychiatry. 2017 Mar 16;17(1):95. doi: 10.1186/s12888-017-1255-9.

46.

Sublingual immunotherapy: A focused allergen immunotherapy practice parameter update.

Greenhawt M, Oppenheimer J, Nelson M, Nelson H, Lockey R, Lieberman P, Nowak-Wegrzyn A, Peters A, Collins C, Bernstein DI, Blessing-Moore J, Khan D, Lang D, Nicklas RA, Portnoy JM, Randolph CR, Schuller DE, Spector SL, Tilles SA, Wallace D.

Ann Allergy Asthma Immunol. 2017 Mar;118(3):276-282.e2. doi: 10.1016/j.anai.2016.12.009. No abstract available.

PMID:
28284533
47.

Mechanisms of anaphylaxis beyond classically mediated antigen- and IgE-induced events.

Lieberman P.

Ann Allergy Asthma Immunol. 2017 Mar;118(3):246-248. doi: 10.1016/j.anai.2017.01.009. Review. No abstract available.

PMID:
28284530
48.

Reply.

Lieberman PL, Umetsu DT, Carrigan GJ, Rahmaoui A.

J Allergy Clin Immunol. 2017 May;139(5):1718-1719. doi: 10.1016/j.jaci.2016.12.976. Epub 2017 Mar 3. No abstract available.

PMID:
28268016
49.

Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).

Bousquet J, Farrell J, Crooks G, Hellings P, Bel EH, Bewick M, Chavannes NH, de Sousa JC, Cruz AA, Haahtela T, Joos G, Khaltaev N, Malva J, Muraro A, Nogues M, Palkonen S, Pedersen S, Robalo-Cordeiro C, Samolinski B, Strandberg T, Valiulis A, Yorgancioglu A, Zuberbier T, Bedbrook A, Aberer W, Adachi M, Agusti A, Akdis CA, Akdis M, Ankri J, Alonso A, Annesi-Maesano I, Ansotegui IJ, Anto JM, Arnavielhe S, Arshad H, Bai C, Baiardini I, Bachert C, Baigenzhin AK, Barbara C, Bateman ED, Beghé B, Kheder AB, Bennoor KS, Benson M, Bergmann KC, Bieber T, Bindslev-Jensen C, Bjermer L, Blain H, Blasi F, Boner AL, Bonini M, Bonini S, Bosnic-Anticevitch S, Boulet LP, Bourret R, Bousquet PJ, Braido F, Briggs AH, Brightling CE, Brozek J, Buhl R, Burney PG, Bush A, Caballero-Fonseca F, Caimmi D, Calderon MA, Calverley PM, Camargos PAM, Canonica GW, Camuzat T, Carlsen KH, Carr W, Carriazo A, Casale T, Cepeda Sarabia AM, Chatzi L, Chen YZ, Chiron R, Chkhartishvili E, Chuchalin AG, Chung KF, Ciprandi G, Cirule I, Cox L, Costa DJ, Custovic A, Dahl R, Dahlen SE, Darsow U, De Carlo G, De Blay F, Dedeu T, Deleanu D, De Manuel Keenoy E, Demoly P, Denburg JA, Devillier P, Didier A, Dinh-Xuan AT, Djukanovic R, Dokic D, Douagui H, Dray G, Dubakiene R, Durham SR, Dykewicz MS, El-Gamal Y, Emuzyte R, Fabbri LM, Fletcher M, Fiocchi A, Fink Wagner A, Fonseca J, Fokkens WJ, Forastiere F, Frith P, Gaga M, Gamkrelidze A, Garces J, Garcia-Aymerich J, Gemicioğlu B, Gereda JE, González Diaz S, Gotua M, Grisle I, Grouse L, Gutter Z, Guzmán MA, Heaney LG, Hellquist-Dahl B, Henderson D, Hendry A, Heinrich J, Heve D, Horak F, Hourihane JOB, Howarth P, Humbert M, Hyland ME, Illario M, Ivancevich JC, Jardim JR, Jares EJ, Jeandel C, Jenkins C, Johnston SL, Jonquet O, Julge K, Jung KS, Just J, Kaidashev I, Khaitov MR, Kalayci O, Kalyoncu AF, Keil T, Keith PK, Klimek L, Koffi N'Goran B, Kolek V, Koppelman GH, Kowalski ML, Kull I, Kuna P, Kvedariene V, Lambrecht B, Lau S, Larenas-Linnemann D, Laune D, Le LTT, Lieberman P, Lipworth B, Li J, Lodrup Carlsen K, Louis R, MacNee W, Magard Y, Magnan A, Mahboub B, Mair A, Majer I, Makela MJ, Manning P, Mara S, Marshall GD, Masjedi MR, Matignon P, Maurer M, Mavale-Manuel S, Melén E, Melo-Gomes E, Meltzer EO, Menzies-Gow A, Merk H, Michel JP, Miculinic N, Mihaltan F, Milenkovic B, Mohammad GMY, Molimard M, Momas I, Montilla-Santana A, Morais-Almeida M, Morgan M, Mösges R, Mullol J, Nafti S, Namazova-Baranova L, Naclerio R, Neou A, Neffen H, Nekam K, Niggemann B, Ninot G, Nyembue TD, O'Hehir RE, Ohta K, Okamoto Y, Okubo K, Ouedraogo S, Paggiaro P, Pali-Schöll I, Panzner P, Papadopoulos N, Papi A, Park HS, Passalacqua G, Pavord I, Pawankar R, Pengelly R, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Poethig D, Pohl W, Popov TA, Portejoie F, Potter P, Postma D, Price D, Rabe KF, Raciborski F, Radier Pontal F, Repka-Ramirez S, Reitamo S, Rennard S, Rodenas F, Roberts J, Roca J, Rodriguez Mañas L, Rolland C, Roman Rodriguez M, Romano A, Rosado-Pinto J, Rosario N, Rosenwasser L, Rottem M, Ryan D, Sanchez-Borges M, Scadding GK, Schunemann HJ, Serrano E, Schmid-Grendelmeier P, Schulz H, Sheikh A, Shields M, Siafakas N, Sibille Y, Similowski T, Simons FER, Sisul JC, Skrindo I, Smit HA, Solé D, Sooronbaev T, Spranger O, Stelmach R, Sterk PJ, Sunyer J, Thijs C, To T, Todo-Bom A, Triggiani M, Valenta R, Valero AL, Valia E, Valovirta E, Van Ganse E, van Hage M, Vandenplas O, Vasankari T, Vellas B, Vestbo J, Vezzani G, Vichyanond P, Viegi G, Vogelmeier C, Vontetsianos T, Wagenmann M, Wallaert B, Walker S, Wang DY, Wahn U, Wickman M, Williams DM, Williams S, Wright J, Yawn BP, Yiallouros PK, Yusuf OM, Zaidi A, Zar HJ, Zernotti ME, Zhang L, Zhong N, Zidarn M, Mercier J.

Clin Transl Allergy. 2017 Feb 20;7:5. doi: 10.1186/s13601-016-0135-6. eCollection 2017.

50.

BET-Inhibitors Disrupt Rad21-Dependent Conformational Control of KSHV Latency.

Chen HS, De Leo A, Wang Z, Kerekovic A, Hills R, Lieberman PM.

PLoS Pathog. 2017 Jan 20;13(1):e1006100. doi: 10.1371/journal.ppat.1006100. eCollection 2017 Jan.

Supplemental Content

Loading ...
Support Center